- Release Date: 20/05/24 09:00
- Summary: CHM CDH17 Phase 1/2 clinical trial approved for initiation
- Price Sensitive: Yes
- Download Document 170.63KB
- Forums
- ASX - By Stock
- CHM
- Ann: CHM CDH17 Phase 1/2 clinical trial approved for initiation
Ann: CHM CDH17 Phase 1/2 clinical trial approved for initiation
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CHM (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online